Hot Features
Premium
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Zeitraum:
Zeichenmodus:
| Volumen | 418 |
|
|||||
| News | - | ||||||
| Tageshoch | 2,96 | Niedrig Hoch |
|||||
| Tagestief | 2,95 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Cyclerion Therapeutics Inc | CYCN | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,25 | 9,23% | 2,96 | 22:05:41 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 2,95 | 2,95 | 2,96 | 2,96 | 2,71 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 28 | 418 | US$ 2,96 | US$ 1.237 | - | 1,7501 - 5,25 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 22:00:00 | 1 | US$ 2,86 | USD |
Finanzwerte CYCN
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 8,02M | 2,71M | - | 0 | -5,26M | -1,94 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Cyclerion Therapeutics
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 07.5.2024 | 22:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 26.1.2024 | 22:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 11.12.2023 | 23:09 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 04.12.2023 | 23:09 | Edgar (US Regulatory) | Form 8-K - Current report |
| 04.12.2023 | 14:00 | GlobeNewswire Inc. | Cyclerion Appoints Regina Graul, Ph.D., as President |
| 01.12.2023 | 14:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 01.12.2023 | 00:16 | GlobeNewswire Inc. | Cyclerion Strengthens Board of Directors with Experienced.. |
| 24.11.2023 | 19:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 13.11.2023 | 22:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 23.10.2023 | 22:58 | Edgar (US Regulatory) | Form 8-K - Current report |
| 31.7.2023 | 13:00 | GlobeNewswire Inc. | Tisento Launches with $81 Million From Top-Tier Investor.. |
| 28.7.2023 | 22:48 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
Forum Cyclerion Therapeutics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
CYCN Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 2,90 | 3,0719 | 2,60 | 2,77 | 940 | 0,06 | 2,07% |
| 1 Monat | 3,04 | 3,1999 | 2,60 | 2,88 | 862 | -0,08 | -2,63% |
| 3 Monate | 3,10 | 3,98 | 2,60 | 3,12 | 2.142 | -0,14 | -4,52% |
| 6 Monate | 2,15 | 5,25 | 1,7501 | 3,35 | 4.900 | 0,81 | 37,67% |
| 1 Jahr | 4,91 | 5,25 | 1,7501 | 3,62 | 7.045 | -1,95 | -39,71% |
| 3 Jahre | 63,80 | 97,20 | 1,7501 | 46,80 | 255.860 | -60,84 | -95,36% |
| 5 Jahre | 303,00 | 311,20 | 1,7501 | 64,70 | 342.626 | -300,04 | -99,02% |
